{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:55:39Z","timestamp":1791096939678,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1994,3,1]],"date-time":"1994-03-01T00:00:00Z","timestamp":762480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Although numerous experimentat immunomodulalory regimens have been reported to be effective in the treatment of rheumatoid arthritis, they also produce undesirable side effects. An alternative specific modality of localized treatment is photodynamic therapy (PDT). In this study we treated 13-week-old MRL-lpr mice whose spontaneous arthritis was enhanced by intradermal injection of Freund's complete adjuvant (FCA). One group received transcutaneous photodynamic therapy at days 0, 10, and 20, following the FCA injection. The other groups were injected with 1 mg\/kg per day indomethacin, 40 mg\/kg per day cyclosporin A (CsA), or treated with 3 Gy sublethal whole body irradiation (WBI). The development of swelling was monitored for 1 month, at which time proteinurca, lymphadenopathy and the histopathology of the joints and kidneys were assessed. The results demonstrated that PDT and the conventional treatments significantly ameliorated swelling of the hindlimbs from 70%in the untreated FCA-injected animals to below the 19% level characteristic of the unmanipulated control. Histological examination showed a reduction in pannus fornamtion, and cartilage and bone destruetion, the characteristics of adjuvant-enhanced arthritis. PDT did not affect the survival rate, lymphoproliferation, or proteinuria of the treated animals. However, indomethacin increased proteinurea, and was less effective in preventing cartilage and bone destruction, furhtermore, lower doses of CsA and WBI exacerbated arthritis activity. These results indicate that photodynamic therapy can inhibit the development of adjuvant-enhanced arthritis in MRL-lpr mice with similar effectiveness to the conventional treatments, but without their negative side effects.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1994.tb07006.x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T14:26:33Z","timestamp":1281623193000},"page":"373-377","source":"Crossref","is-referenced-by-count":26,"title":["Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL-lpr mice"],"prefix":"10.1093","volume":"95","author":[{"given":"L G","family":"RATKAY","sequence":"first","affiliation":[{"name":"Department of Oral Biology, Faculty of Dentistry, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R K","family":"CHOWDHARY","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of British Columbia, Canada"},{"name":"Quadra Logic Inc., vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H C","family":"NEYNDORFF","sequence":"additional","affiliation":[{"name":"Quadra Logic Inc., vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"TONZETICH","sequence":"additional","affiliation":[{"name":"Department of Oral Biology, Faculty of Dentistry, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"WATERFIELD","sequence":"additional","affiliation":[{"name":"Department of Oral Biology, Faculty of Dentistry, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J G","family":"LEVY","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of British Columbia, Canada"},{"name":"Quadra Logic Inc., vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011617132308800_b1","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous murine lupus-iike syndromes. Clinical and immunopathological manifestations in several strains","volume":"148","author":"Andrews","year":"1978","journal-title":"J Exp Med"},{"key":"2022011617132308800_b2","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1084\/jem.155.6.1690","article-title":"A spontaneous rheumatoid arthrilis-likediseascin MRL\/lmiee","volume":"155","author":"Hang","year":"1982","journal-title":"J Exp Med"},{"key":"2022011617132308800_b3","first-page":"3","article-title":"Biisie elements of murine systemic lupus erythemalosus","volume":"14","author":"DIxon","year":"1987","journal-title":"J Rheumalot Suppl."},{"key":"2022011617132308800_b4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0090-1229(91)90021-2","article-title":"Antibodies to extracellular matrix proicins in the sera of MRL-lpr mice","volume":"59","author":"Ratkay","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011617132308800_b5","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.4049\/jimmunol.151.9.5081","article-title":"Complete FrcLind's adjuvant induces an earlier and more severe arthritis in MRL-lpr mice","volume":"151","author":"Ratkay","year":"1993","journal-title":"J Immunol"},{"key":"2022011617132308800_b6","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.4049\/jimmunol.125.5.2137","article-title":"Inhibition of T cells proliferation and SLF-like syndrome of MRL\/I mice by whole body or totlal lymphoid irradiation","volume":"125","author":"Theofilopoulos","year":"1980","journal-title":"J Immunol"},{"key":"2022011617132308800_b7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4049\/jimmunol.125.2.871","article-title":"EtTeels of thymectomy or androgen administration upon the autoimmune disease of MRL.MRL\/Mp-\/pr\/lpr mice","volume":"125","author":"Steinberg","year":"1980","journal-title":"J Immunol"},{"key":"2022011617132308800_b8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4049\/jimmunol.138.1.157","article-title":"CS-A therapy in MRL-lpr\/lpr miee: amelioration of immunopathology despite iiutoantibody production","volume":"138","author":"Mountz","year":"1987","journal-title":"J Immunol"},{"key":"2022011617132308800_b9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-3083.1986.tb02128.x","article-title":"Effect of cyclosporin A on autoimmune disease in MRL\/1 and BXSB miee","volume":"24","author":"Bcrden","year":"1986","journal-title":"Seand J Immunol"},{"key":"2022011617132308800_b10","doi-asserted-by":"crossref","first-page":"852","DOI":"10.4049\/jimmunol.134.2.852","article-title":"Treatment of murine lupus with monoelonal anti-T cell aniibody","volume":"134","author":"Wofsy","year":"1985","journal-title":"J Immunol"},{"key":"2022011617132308800_b11","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.4049\/jimmunol.130.4.1713","article-title":"Treatment of autoimmune MRL\/lpr mice with monoeionalantibody to Thy-l.2:a single injection has sustained effects on lymphoproliferation and renal disease","volume":"130","author":"Seaman","year":"1983","journal-title":"J Immunol"},{"key":"2022011617132308800_b12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1084\/jem.167.5.1713","article-title":"The contribution of L3T4 T cells to lymphoproliferation and autoantibody production in MRL\/lpn\/lpr mice","volume":"167","author":"Santoro","year":"1988","journal-title":"J Exp Med"},{"key":"2022011617132308800_b13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/eji.1830170809","article-title":"The role of L3T4+ cells in the pathogenesis of lupus in lpr-bearing mice. I. Defects in the production of interleukins 2 and 3","volume":"17","author":"Santoro","year":"1987","journal-title":"Eur J Immunol"},{"key":"2022011617132308800_b14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0090-1229(05)80013-3","article-title":"Longterm anti-CD4 treatment of MRL\/lpr mice ameliorates immunopathology and lymphoprolileration but fails to suppress rheumatoid factor produetion","volume":"61","author":"O'Suliivan","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011617132308800_b15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0090-1229(92)90195-T","article-title":"Effeet of anti-CD4 aniibody treatment on intlamtnatory arthritis in MRL-lpr\/lpr mice","volume":"64","author":"Gilkeson","year":"1992","journal-title":"Clin Immunoi Immunopalhol"},{"key":"2022011617132308800_b16","first-page":"341","article-title":"Arthritis in MRL\/lpr mice and in collagen ll sensitized DBA-1 mice and their use in pharmacology","volume":"9","author":"Rordorf","year":"1987","journal-title":"Int J Tissue React"},{"key":"2022011617132308800_b17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01971233","article-title":"The effects of anti-inflammatory agents on the serology and arthritis of the MRL Ipr\/lpr mouse","volume":"19","author":"Rordorf-Adam","year":"1986","journal-title":"Agenis Actions"},{"key":"2022011617132308800_b18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.6336851","article-title":"Lines of T lymphocytes induce or vaccinate againsl autoimmune arthritis","volume":"219","author":"Holoshitz","year":"1983","journal-title":"Science"},{"key":"2022011617132308800_b19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/1523-1747.ep12873349","article-title":"Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinaclivated lymphocytes","volume":"94","author":"Bcrger","year":"1990","journal-title":"J Invest Dermatol"},{"key":"2022011617132308800_b20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1751-1097.1990.tb01791.x","article-title":"In vilro evaluation of photoloxic properties of four structurally related benzoporphyrin derivatives","volume":"52","author":"Richter","year":"1990","journal-title":"Photochem Photobiol"},{"key":"2022011617132308800_b21","first-page":"132","article-title":"Characterization of benzoporphyrin derivative, a new photosensitizer","volume":"997","author":"Richter","year":"1988","journal-title":"SPIE"},{"key":"2022011617132308800_b22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1751-1097.1992.tb04222.x","article-title":"How does photodynamic therapy work","volume":"55","author":"Henderson","year":"1992","journal-title":"Pholochem Photobiol"},{"key":"2022011617132308800_b23","first-page":"147","article-title":"Photodynamic therapy of maligniinl skin tumors wiih Benzoporphyrin derivalive-monoacid ring A (BPD-MA): preliminary observations","volume":"1876","author":"Lui HruzaL","year":"1993","journal-title":"SPIE"},{"key":"2022011617132308800_b24","first-page":"50S","article-title":"Photodynamic therapy of psoriasis; preliminary evaluation of benzoporphyrin derivative monoacid ring A(BPD-MA)","volume":"57","author":"Hruza","year":"1993","journal-title":"Photoehem Photobiol"},{"key":"2022011617132308800_b25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1751-1097.1991.tb03935.x","article-title":"Mouse skin pholosensitization with benzoporphyrin derivatives and Photofrin: macroscopic and microscopic evaluation","volume":"53","author":"Riehter","year":"1991","journal-title":"Photochem Photobiol"},{"key":"2022011617132308800_b26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/1011-1344(93)80002-Q","article-title":"Pholosensitizers as virueldal agents","volume":"17","author":"North","year":"1993","journal-title":"J Photoehem Photobiol B: Biol"},{"key":"2022011617132308800_b27","article-title":"Aetivation of Benzoporphyrin derivative in the circulation of mice without skin photoscnsitivity","author":"Riehter","year":"1993","journal-title":"Photochem Photobiol"},{"key":"2022011617132308800_b28","first-page":"27","article-title":"Rheumatoid arthritis- its present and future","volume":"171","author":"Ziff","year":"1990","journal-title":"J Rheumatol"},{"key":"2022011617132308800_b29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/rheumatology\/29.1.58","article-title":"Immunogenetic and cellular mechanisms in rheumatoid arlhritis: relevanee to new therapeutic strategies","volume":"29","author":"Kingsley","year":"1990","journal-title":"Br J Rheumatol"},{"key":"2022011617132308800_b30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3181\/00379727-91-22179","article-title":"Development of arthritis, periarthritis, and periostitis in rats given adjuvant","volume":"91","author":"Pearson","year":"1956","journal-title":"Proc Soc Exp Bioi Med"},{"key":"2022011617132308800_b31","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/art.1780200614","article-title":"Lymphocyte involvement in rheumatoid arthritis--studies during thoracic duct drainage","volume":"20","author":"Paulus","year":"1977","journal-title":"Arthritis Rheum"},{"key":"2022011617132308800_b32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/rheumatology\/25.1.40","article-title":"Lymphocylapheresis-a feasible treaiment for rheumatoid arthritis","volume":"25","author":"Emery","year":"1986","journal-title":"Br J Rheumatol"},{"key":"2022011617132308800_b33","first-page":"127","article-title":"Dissection of mechanisms of mimune injury in rheumatoid arthritis using total lymphoid irradiation","volume":"47","author":"Gaslon","year":"1988","journal-title":"Anhritis Rheum"},{"key":"2022011617132308800_b34","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","volume":"321","author":"Kahan","year":"1989","journal-title":"EngI J Med"},{"key":"2022011617132308800_b35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002281-199106000-00005","article-title":"Immunosuppressive therapy for rheumatic disease","volume":"3","author":"McCune","year":"1991","journal-title":"Curr Opin Rheumatol"},{"key":"2022011617132308800_b36","article-title":"Non-oneologie potentials for photodynamic therapy","author":"Richter","year":"1993","journal-title":"SPIE"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1994.tb07006.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/95\/3\/373\/42210222\/j.1365-2249.1994.tb07006.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/95\/3\/373\/42210222\/j.1365-2249.1994.tb07006.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:10:03Z","timestamp":1740381003000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/95\/3\/373\/6490880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1994.tb07006.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1994,3]]},"published":{"date-parts":[[1994,3]]}}}